Cybin Corp. is focused on furthering the research and development of psilocybin through its wholly-owned subsidiary, Serenity Life Sciences Inc., and developing proprietary medicinal mushroom products through its wholly-owned subsidiary, Natures Journey Inc.
The company's IP strategy revolves around psychedelic delivery mechanisms, synthetic compounds, extraction methods, isolation of chemical compounds, new drug formulations and protocol regiments. Its experienced management team has run multiple clinical trials and successfully brought many new drugs to market in the past.
Co-Founder & SVP Business Development
Co-Founder & President